TREEFROG
LIVE

Serial Number

79319289

Owner

TREEFROG THERAPEUTICS

Attorney

Todd A. Denys

Filing Date

May 3, 2021

Add to watchlist:

No watchlists yet
View on USPTO

TREEFROG Trademark

Serial Number: 79319289 • Registration: 6854642

TREEFROG is a trademark filed by TREEFROG THERAPEUTICS on May 3, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

TREEFROG THERAPEUTICS (11 trademarks)

30 Avenue Gustave Eiffel, Bâtiment A

Entity Type: 34

Trademark Details

Filing Date

May 3, 2021

Registration Date

September 27, 2022

Published for Opposition

July 12, 2022

Goods & Services

Laboratory research in the field of biotechnology; scientific research on stem cells; scientific research on the production of pluripotent stem cells by encapsulation; research and development in the field of stem cells, cell and gene therapy and biotechnology; pharmaceutical research and development; scientific laboratory services; providing information with respect to scientific research in the field of stem cells, cell and gene therapy and biotechnology

Scientific apparatus for cell culture systems, namely cytometers and biomimetic 3D culture systems composed of cell culture dishes for cell culture systems; scientific apparatus for the analysis and sorting of cell culture, namely laboratory pipettes and capsules for the analysis and sorting of cell culture; bioreactors for cell culture; observation apparatus for cell culture, namely microscopes for cell culture; incubators for cell culture; cell culture apparatus for laboratory use, namely cell culture dishes and tissue culture flaks; downloadable computer software used for the collection, analysis, sorting and communication of biological information relating to stem cells

Stem cells for research; stem cells for scientific purposes; nutrition agents for processing living cells other than for medical purposes; cell culture media for laboratory use, other than for medical purposes

Apparatus for the regeneration of stem cells for medical use; apparatus for cell culture systems for medical purposes, namely cell culture chambers and capsules; apparatus for encapsulation of cell culture systems for medical purposes; apparatus for analyzing and sorting cell culture for medical purposes

Pharmaceutical products for the treatment of Parkinson's disease and neurodegenerative diseases, heart disease, diabetes, Non-Alcoholic Steatohepatitis and acute liver failure, Age-related macular degeneration and limbal stem cells deficiencies, traumatic injury, skin burns, spinal cord injuries, huntington disease, amyotrophic lateral sclerosis, Alzheimer's disease, stroke, burns, cancer, osteoarthritis, Multiple Sclerosis, Radiation Induced Intestinal Injury, Inflammatory Bowel Disease, Liver Disease, Duchenne Muscular Dystrophy, Bone Disease, Renal Disease, Chronic Wounds, Graft-Versus-Host Disease, Sepsis and Respiratory diseases; pharmaceutical preparations for the treatment of Parkinson's disease and neurodegenerative diseases, heart disease, diabetes, Non-Alcoholic Steatohepatitis and acute liver failure, Age-related macular degeneration and limbal stem cells deficiencies, traumatic injury, skin burns, spinal cord injuries, huntington disease, amyotrophic lateral sclerosis, Alzheimer's disease, stroke, burns, cancer, osteoarthritis, Multiple Sclerosis, Radiation Induced Intestinal Injury, Inflammatory Bowel Disease, Liver Disease, Duchenne Muscular Dystrophy, Bone Disease, Renal Disease, Chronic Wounds, Graft-Versus-Host Disease, Sepsis and Respiratory diseases; stem cells for medical or veterinary use; pluripotent stem cells intended for cell and gene therapies for medical use; cell culture media for medical or veterinary use, namely, culture media for cultivating human cells and microorganism cells; surgical implants comprising living tissue obtained from stem cells

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Feb 12, 2026 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 14, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 23, 2023 FICS
FINAL DISPOSITION PROCESSED
Jan 23, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 27, 2022 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 27, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 27, 2022 R.PR
NOTIFICATION PROCESSED BY IB
Jul 18, 2022 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 12, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jul 12, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 29, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 29, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 22, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 6, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 6, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 6, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 6, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 6, 2022 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jun 4, 2022 ZZZX
WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST
Jun 4, 2022 PBSR
APPROVED FOR PUB - PRINCIPAL REGISTER
May 31, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 11, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 10, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 10, 2022 TROA
REFUSAL PROCESSED BY IB
Feb 20, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 29, 2022 RFCS
REFUSAL PROCESSED BY MPU
Jan 28, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 8, 2022 RFCR
NON-FINAL ACTION WRITTEN
Jan 7, 2022 CNRT
ASSIGNED TO EXAMINER
Jan 5, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 14, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 8, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 2, 2021 REPR